Home   About the Journal  Editorial Board  Online Journal   Publishing Ethics   Contact Us  Chinese Version
You are here:Home => Online Journal => 7期肝癌的诊断和治疗 => 专家论坛 =>
Value of Gd-EOB-DPTA in the diagnosis of hepatocellular carcinoma
文章发布日期:2018年06月07日  来源:  作者:李若坤,严福华,李克  点击次数:803次  下载次数:128次
Adjust font size:Small regular big

【Abstract】:Gd-EOB-DPTA is a hepatocyte-specific contrast agent with the function of double-contrast imaging. It can reflect the blood supply of lesions via dynamic enhancement imaging and show the change in the expression of molecular receptors on hepatocyte membrane via hepatobiliary phase imaging. Gd-EOB-DPTA can reflect the multistep process of hepatocarcinogenesis from multiple dimensions, improve detection of hypovascular hepatocellular carcinoma (HCC) and small HCC, display cirrhotic nodules with high-risk malignant transformation, and therefore, it has been recommended as a noninvasive tool for HCC diagnosis in China and international HCC clinical practice guidelines. This article reviews the recent advances of Gd-EOB-DTPA in the diagnosis of HCC.
【Key words】:carcinoma, hepatocellular; gadoxetic acid; diagnosis

Mail address: Editorial Office of Journal of Clinical Hepatology, 519 Dongminzhu Street, Changchun, Jilin, China Postal code: 130061 Tel:+86-431-88782542/3542
Journal of Clinical Hepatology Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号